Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

Not exactly.

The article confirms Dr Degrado, IPIX science advisor, is acknowledged by his peers as a leading researcher in the field of proteins, peptides
and defensins as well as defensin based pharmaceuticals.

Brilacidin is based structurally on a defensin peptide, Magainin. Attempts to make Magainin a therapeutic failed to to the structural weakness in its peptide core.

Dr Degrado and his team used biochemical and supercomputer enhancement to produce a new pharmacologically stable compound with superior antibiotic, anti-inflammatory and now antiviral capabilities, Brilacidin.

Having Dr DeGrado give a portion of a named lecture in his field is an honor .

Having Dr Degrado as IPIX's scientific advisor gives IPIX and Brilacidin scientific and academic credibility that is priceless.

Brilacidin research is just beginning to open its multiple possible uses as a pharmacologic agent.

GLTA,Farrell